Novartis defends Vildagliptin patent

Novartis defends Vildagliptin patent

Novartis has successfully defended its patent for Vildagliptin and is committed to its mission of innovation in the Vietnamese healthcare sector.
Sandoz enters a new era as independent firm

Sandoz enters a new era as independent firm

Sandoz has successfully completed its separation from Novartis with its first trading day on the SIX Swiss Exchange.
Pharma giants gaining big in 2022

Pharma giants gaining big in 2022

International pharma giants have reported strong results for the first half of 2022, with new plans in the pipeline from many of them in this country.
Pharma firms reveal stellar 2021 business

Pharma firms reveal stellar 2021 business

International pharma giants Novartis, Sanofi, Pfizer, and MSD had solid business performances during 2021, with a bumper year forecast for the whole of this year driven by vaccines and treatment pills.
Novartis – A success story for a quarter of a century with great plans forward

Novartis – A success story for a quarter of a century with great plans forward

Novartis has made great breakthroughs over the past 25 years. Amitabh Dube, country president at Novartis Vietnam, discussed with VIR’s Bich Thuy the great journey and future plans ahead.
COVID-19 – the first step for businesses to perfect HR policies

COVID-19 – the first step for businesses to perfect HR policies

In a challenging 2021 businesses are heading to technology and the digital space to operate and maintain the office culture.
Novartis and Ministry of Health sign MoU on portfolio of affordable COVID-19 medicines

Novartis and Ministry of Health sign MoU on portfolio of affordable COVID-19 medicines

Novartis and Vietnam’s Ministry of Health have signed an MoU to provide affordable medicines without a profit for the treatment of severe COVID-19 symptoms.
25 years of development - Novartis affirms long-term commitments to community health

25 years of development - Novartis affirms long-term commitments to community health

Novartis on November 22 celebrated its 25th anniversary to mark its development in Vietnam and affirm its leading global position in healthcare.
Stakeholders discuss solutions to improve hospitalisation in Vietnam

Stakeholders discuss solutions to improve hospitalisation in Vietnam

HSPI and Novartis Vietnam organised a workshop to discuss improving appropriate hospitalisation to enhance the operational effectiveness of the health system.
Stakeholders help improve accessibility of eye health services in Vietnam

Stakeholders help improve accessibility of eye health services in Vietnam

Stakeholders have joined hands to help improve the accessibility of eye health services for the most vulnerable in Vietnam.
Ho Chi Minh City University and Novartis implement training on heart failure management

Ho Chi Minh City University and Novartis implement training on heart failure management

Novartis Vietnam has collaborated with Ho Chi Minh City University Medical Centre to implement the online Medical Training Programme for nursing staff on heart failure management from May 2021.
Novartis partners with local healthcare units to enhance public health awareness

Novartis partners with local healthcare units to enhance public health awareness

Novartis Vietnam will collaborate with local health organisations and Hello Bacsi to leverage the latter’s digital ecosystem and improve disease awareness.
Novartis launches project to strengthen primary healthcare in Khanh Hoa

Novartis launches project to strengthen primary healthcare in Khanh Hoa

Novartis Vietnam collaborated with Khanh Hoa authorities to kick off the project to strengthen primary healthcare in the central province.
Novartis brings pioneer online medical platform to Vietnam

Novartis brings pioneer online medical platform to Vietnam

Aiming to offer an exclusive digital network for medical staff, Novartis Vietnam Ltd. has recently teamed up with Docquity Holdings Pte., Ltd. to bring the Docquity online platform to Vietnam.  
Restrictions curbing success of pharma groups of all sizes

Restrictions curbing success of pharma groups of all sizes

Amid a lacklustre picture in the market, domestic pharma giants are attempting to cut costs to weather the storm of COVID-19, while multinational corporations like F. Hoffmann-La Roche, AstraZeneca, and Novartis are making new preparations.
1 2